1.Evaluation on different dosage of 5-aminosalicylic acid zinc enteric-coated capsule in treatment of active ulcerative colitis: multi-centre randomized double-blind double-dummy controlled trial
Yingyong LIN ; Xianghong QIN ; Yaozong YUAN ; Zhigang TAN ; Haitang HU
Chinese Journal of Digestion 2010;30(4):263-266
Objective To evaluate the efficacy and safety of two kinds of dosage of 5-aminosalicylic acid zinc enteric-coated capsule in treatment of active ulcerative colitis (UC). Methods The muhicentre, double blind, dosage reaction and contrast trial was conducted in six hospitals during March 2004 to Sep. 2004. One hundred and eight patients with UC were randomly allocated into the high dosage (n= 36, 1 g, bid) and the low dosage (n = 36, 0.5 g, bid) of 5-aminosalicylic acid zinc enteric-coated capsule groups, and the Olsalazine sodium group (n = 36, 1 g, tid) with a 8-week treatment. The efficacy and adverse events of 5-aminosalicylic acid zinc enteric-coated capsule were evaluated based on the clinical presentations and endoscopic findings. Results The clinical efficacy was 68.97% in high dosage group, 45. 45% in low dosage group and 62.86% in Olsalazine sodium group with no significant difference (P>0. 05). The endoscopic examination showed that the healing rate of UC in high dosage group and low dosage group was 51.72% and 21.21%, respectively, whereas the efficacy rate was 82.76% and 69.70% respectively. The results showed that high dosage was more effective than low dosage (P=0.023), but was similar to Olsalazine sodium (healing rate of 34.29% and effective rate of 88.57% ,P>0. 05). Diarrhea was main adverse event, which was accounted for 2.8% (1/36) in high dosage group and 2.8% (1/36) in the Olsalazine sodium group. There was no adverse event in low dosage group. Conclusions 5-aminosalicylic acid zinc enteric-coated capsule is an effective agent in treatment of UC, especially in high dosage. It is similar to Olsalazine sodium in treatment of UC, and has advantages in reducing medication times.
2.Evaluation of the effect of ilaprazole on intragastrtc pH in patients with duodenal ulcer
Liya ZHOU ; Sanren LIN ; Yunsheng YANG ; Shutian ZHANG ; Yaozong YUAN ; Ruihua SHI ; Xiaohua HOU ; Jielai XIA ; Haitang HU ; Xianghong QIN
Chinese Journal of Internal Medicine 2010;49(4):290-292
Objective To evaluate the effect of ilaprazole enteric tablets on intragastric pH in duodenal ulcer patients. Methods A randomized, double blind, positive controlled clinical trial was carried out. A total of forty-two patients with duodenal ulcer were randomized into low dose ilaprazole group (5 mg/d), medium dose ilaprazole group (10 mg/d), high dose ilaprazole group(20 mg/d) and omeprazole group(20 mg/d). An ambulatory 24 hour intragastric pH study was performed at the fifth treatment day. Fraction time pH above 3, 4 or 5, median values of 24 hour diurnal pH and 12 hour nocturnal pH, the percentage of patients with total time pH above 3, 4 or 5 at least for 18 hours were evaluated. Results There were no significant differences of fraction time pH above 3 or 4, median values of 24 hour diurnal pH and 12 hour nocturnal pH and the percentage of patients with total time pH above 3, 4 or 5 at least for 18 hours among all the groups with different doses of ilaprazole and the omeprazole group. The fraction time pH above 5 in medium and high dose ilaprazole groups were (87.96 ± 12. 29)% and (89.86±15. 18)% respectively, which was higher than that in low dose ilaprazole group [(67. 17± 30. 16)%] and omeprazole group[(76. 14 ± 16. 75)%], P <0. 05. Conclusion Ilaprazole has a strong effect on intragastric acid control with a dose dependent trend.
3.Application and administration of midline catheter in patients with renal transplantation
Zhen LIU ; Lianna MAO ; Zhaohui WANG ; Haitang YUAN ; Limei ZHUANG
Chinese Journal of Modern Nursing 2019;25(32):4216-4218
Objective? To investigate the effect of midline catheter in intravenous treatment after renal transplantation. Methods? From May 2018 to February 2019, 84 renal transplant patients were treated with central line catheters, which were placed through cubital fossa or superior superficial cubital vein. The length of catheters was 22-36 cm. During catheterization, the maintenance of catheters was well done, the prevention and treatment of complications were emphasized, and the situation of catheter extraction was observed. Results? Totally 84 patients had catheter indwelling time of 10-41 days, 2 cases of puncture point oozing, 2 cases of tube plugging, 2 cases of shoulder pain, 1 case of upper extremity edema. After careful care and treatment, no serious complications occurred and the effect was satisfactory. Conclusions? The application of midline catheter vein treatment, without repeated venipuncture, reduces the pain of patients′ puncture and the occurrence of phlebitis, achieves the expected treatment effect, and reduces the workload of nurses.